Mitochondrial Myopathies Market to Register Stunning Growth at a CAGR of 26.5% During the Forecast Period (2025-2034) Driven by Recent Approvals and Pipeline Advancements and ...

DelveInsight's Mitochondrial Myopathies Market Insights report includes a comprehensive understanding of current treatment practices, mitochondrial myopathies emerging drugs, market share of ...
Cantech Letter

Thiogenesis Therapeutics Expands on Plans for Phase 3 Pivotal Trial of TTI-0102 in Nephropathic Cystinosis

IND expected in early 2026; TTI-0102 designed to improve tolerability & simplify dosing San Diego, California–(Newsfile Corp. – November 24, 2025) – Thiogenesis Therapeutics, Corp. (TSXV: TTI) ...